Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Mechanisms of methotrexate resistance in osteosarcoma.

Guo W, Healey JH, Meyers PA, Ladanyi M, Huvos AG, Bertino JR, Gorlick R.

Clin Cancer Res. 1999 Mar;5(3):621-7.

2.

Molecular mechanisms of resistance to antifolates, a review.

Banerjee D, Ercikan-Abali E, Waltham M, Schnieders B, Hochhauser D, Li WW, Fan J, Gorlick R, Goker E, Bertino JR.

Acta Biochim Pol. 1995;42(4):457-64. Review.

3.

Resistance mechanisms to methotrexate in tumors.

Bertino JR, Göker E, Gorlick R, Li WW, Banerjee D.

Stem Cells. 1996 Jan;14(1):5-9. Review.

4.

Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.

Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R, Bertino JR.

Biochim Biophys Acta. 2002 Jul 18;1587(2-3):164-73. Review.

5.
6.

Mechanisms of methotrexate resistance in acute leukemia. Decreased transport and polyglutamylation.

Gorlick R, Cole P, Banerjee D, Longo G, Li WW, Hochhauser D, Bertino JR.

Adv Exp Med Biol. 1999;457:543-50. Review.

PMID:
10500832
7.

Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application.

McIvor RS.

Bone Marrow Transplant. 1996 Dec;18 Suppl 3:S50-4. Review.

PMID:
8971409
8.

Cellular and molecular mechanisms of resistance to antifolate drugs: new analogues and approaches to overcome the resistance.

Takemura Y, Kobayashi H, Miyachi H.

Int J Hematol. 1997 Dec;66(4):459-77. Review. Erratum in: Int J Hematol 1998 Apr;67(3):333.

PMID:
9479873
9.

The methotrexate story: a paradigm for development of cancer chemotherapeutic agents.

Huennekens FM.

Adv Enzyme Regul. 1994;34:397-419. Review.

PMID:
7942284
10.

Molecular basis of antifolate resistance.

Assaraf YG.

Cancer Metastasis Rev. 2007 Mar;26(1):153-81. Review.

PMID:
17333344
11.

Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia.

Matherly LH, Taub JW.

Leuk Lymphoma. 1996 May;21(5-6):359-68. Review.

PMID:
9172800
12.

Gene amplification and altered enzymes as mechanisms for the development of drug resistance.

Bertino JR, Carman MD, Weiner HL, Cashmore A, Moroson BA, Srimatkandada S, Schornagel JH, Medina WD, Dube SK.

Cancer Treat Rep. 1983 Oct;67(10):901-4. Review.

PMID:
6354438
13.

[Acquisition of resistance to anticancer agents by overproduction of target enzymes].

Inaba M.

Nihon Rinsho. 1997 May;55(5):1030-7. Review. Japanese.

PMID:
9155148
14.

Tumor resistance to antimetabolites.

Kinsella AR, Smith D.

Gen Pharmacol. 1998 May;30(5):623-6. Review.

PMID:
9559310
15.

Gene amplification and drug resistance in cultured animal cells.

Schimke RT, Beverley S, Brown P, Cassin R, Federspiel N, Gasser C, Hill A, Johnston R, Mariani B, Mosse E, et al.

Cancer Treat Rev. 1984 Mar;11 Suppl A:9-17. Review. No abstract available.

PMID:
6375865
16.

Biochemical mechanisms of resistance to antimetabolites.

Harrap KR, Jackson RC.

Antibiot Chemother (1971). 1978;23:228-37. Review. No abstract available.

PMID:
348081
18.

Gene amplification in cultured animal cells.

Schimke RT.

Cell. 1984 Jul;37(3):705-13. Review. No abstract available.

PMID:
6378386
19.

[Molecular mechanisms of cellular resistance to antifolates].

Grzelakowska-Sztabert B.

Postepy Biochem. 1983;29(2):167-90. Review. Polish. No abstract available.

PMID:
6371748
20.

[Resistance mechanisms to Methotrexate].

Jin M, Wu MY.

Zhonghua Er Ke Za Zhi. 2003 May;41(5):388-90. Review. Chinese. No abstract available.

PMID:
14751076
Items per page

Supplemental Content

Write to the Help Desk